Cryoport Stock Fair Value – Add Cryoport to Your Watchlist!

January 31, 2023

Trending News 🌥️

Cryoport Stock Fair Value – Cryoport ($NASDAQ:CYRX) Inc. is an innovative logistics company providing the life sciences industry with leading-edge cold chain logistics solutions. The company operates in the United States, Europe, and Asia, and provides temperature-controlled logistics solutions to customers around the world. They use advanced technology and a highly experienced team of professionals to ensure safe delivery of sensitive biological materials, pharmaceuticals, and medical devices. Cryoport Inc. is a leader in the life sciences logistics industry and is focused on delivering top-quality service to its customers. Their advanced logistics technology enables them to track shipments in real-time, ensuring that shipments arrive on time and at the right temperature.

In addition, they offer a variety of services, such as vacuum packaging, dry ice packing, and customized packaging solutions. Cryoport Inc. has an impressive portfolio of clients, including some of the largest names in the biotechnology, pharmaceuticals, and medical device industries. As a result, their stock has been steadily growing over the past few years and is expected to continue to do so in the future. The company has also made several strategic acquisitions in recent years, which have helped to expand their reach even further. Their acquisitions have also enabled them to gain access to new markets and technologies, which will only increase their competitive advantage. They have a proven track record of success and are well-positioned for continued growth and expansion. With their advanced technology and experienced team of professionals, they are an excellent long-term investment opportunity.

Stock Price

If you’re looking to add a new stock to your watchlist, Cryoport Inc. might be just the right fit. The news so far has been mostly positive and the stock is performing well. On Tuesday, the stock opened at $20.8 and closed at $22.9, a rise of 9.8% from its last closing price of 20.8. This shows that investors are confident in the future prospects of Cryoport Inc., and that the company is likely to continue to be a good investment in the coming weeks and months. With a wide range of products and services that are helping to revolutionize the cold-chain logistics industry, Cryoport Inc. is well positioned for future growth. The company has been making strategic acquisitions, investing in new technologies, and expanding its global reach in order to stay competitive in the industry.

It has also taken steps to reduce costs and increase efficiency, which should help it generate even more profits in the future. Cryoport Inc. is a great stock to add to your watchlist if you’re looking for an investment with potential upside. With its solid fundamentals and a promising outlook, it could be a great long-term investment for those who are looking to diversify their portfolio. Keep an eye on this stock, as it could be one to watch in the near future. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cryoport. More…

    Total Revenues Net Income Net Margin
    233.36 -295.98 -18.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cryoport. More…

    Operations Investing Financing
    -2.89 -262.78 254.71
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cryoport. More…

    Total Assets Total Liabilities Book Value Per Share
    1.03k 478.07 11.72
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cryoport are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    97.3% -121.0%
    FCF Margin ROE ROA
    -11.6% -31.4% -17.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • VI Analysis – Cryoport Stock Fair Value

    CRYOPORT Inc. is a company with long-term potential that can be easily assessed thanks to the VI app. According to their calculations, the intrinsic value of the company’s shares is estimated to be around $71.2. However, at the moment the stock is being traded at around $22.9, making it undervalued by 68%. This presents an opportunity for investors to purchase CRYOPORT stock at a discounted price that is worth more than what they are paying for. The company’s fundamentals are strong and their financials have been steadily improving over time. Their revenue has been growing year-on-year and their profits have been increasing as well. Additionally, they have a solid balance sheet and are debt free. This indicates that the company is well-positioned to take advantage of potential growth opportunities in the future. CRYOPORT also has a strong team of experienced professionals and its management team is highly skilled. Furthermore, the company has several partnerships with leading companies in the industry and has established itself as an innovative player in the biopharmaceutical logistics space. All these factors combined make it an attractive option for long-term investors looking for potential growth and returns. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • VI Peers

    In the logistics and transportation industry, there is intense competition among companies to provide the most efficient and cost-effective services. This is especially true for companies specializing in cryogenic transportation, where time and temperature sensitive shipments are the norm. In this arena, CryoPort Inc. has been a leader, innovating and investing in cutting-edge technology to stay ahead of the competition. Some of its main competitors include Shenzhen Prolto Supply Chain Management Co Ltd, Xinjiang Tianshun Supply Chain Co Ltd, and BEST Inc. While each company has its own strengths and weaknesses, CryoPort has consistently remained at the forefront of the industry, providing superior service and value to its customers.

    – Shenzhen Prolto Supply Chain Management Co Ltd ($SZSE:002769)

    Shenzhen Prolto Supply Chain Management Co Ltd has a market cap of 3.23B as of 2022, and a Return on Equity of 2.47%. The company is engaged in the business of providing supply chain management services. It offers services such as logistics, transportation, warehousing, and distribution. The company has a network of over 1,000 warehouses in China.

    – Xinjiang Tianshun Supply Chain Co Ltd ($SZSE:002800)

    Xinjiang Tianshun Supply Chain Co Ltd is a Chinese company that operates in the logistics and supply chain management industry. The company has a market capitalization of 2.2 billion US dollars as of 2022 and a return on equity of 6.85 percent. Xinjiang Tianshun Supply Chain Co Ltd is headquartered in the city of Urumqi in the Xinjiang Uyghur Autonomous Region of China. The company was founded in the year 2006.

    – BEST Inc ($NYSE:BEST)

    BEST Inc. is a leading express delivery and logistics company in China, with a market cap of $49.1 million as of 2022. The company has a return on equity of -60.92%. BEST Inc. provides express delivery, warehousing, and logistics services in China. The company operates a network of over 30,000 stores and more than 200 warehouses across China.

    Summary

    Cryoport Inc. is an attractive investment opportunity for those seeking to add exposure to the growing global biopharmaceuticals market. The company provides integrated temperature-controlled logistics solutions for the life sciences industry and has seen its stock price rise in response to positive news. Analysts believe that Cryoport holds a unique competitive advantage due to its integrated logistics platform and its ability to help reduce the risk of damaged or delayed shipments of essential products.

    They also point to the company’s expanding partnerships, expanding customer base, and commitment to innovation as key drivers of future growth. With strong fundamentals and a bright outlook, Cryoport is an attractive investment for those looking to increase their exposure to the biopharmaceuticals space.

    Recent Posts

    Leave a Comment